{
    "clinical_study": {
        "@rank": "35237", 
        "acronym": "REPRECIN", 
        "arm_group": [
            {
                "arm_group_label": "RenalGuard", 
                "arm_group_type": "Active Comparator", 
                "description": "Hydration with the device renalguard"
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "No Intervention", 
                "description": "Hydration with saline 1ml/Kg/h for 12h"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether hydration with intravenous saline matched\n      with urine output, using the device RenalGuard is superior to standard hydration with saline\n      to prevent contrast-induced nephropathy."
        }, 
        "brief_title": "RenalGuard System for Prevention of Contrast Induced Nephropathy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Radiographic Contrast Agent Nephropathy", 
        "condition_browse": {
            "mesh_term": "Kidney Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  serum creatinine >1.2mg/dl\n\n          -  glomerular filtration rate (GFR) < 60ml/min\n\n        Exclusion Criteria:\n\n          -  acute renal failure\n\n          -  use of radiological contrast in the latest 7 days\n\n          -  Current use of N-acetylcysteine or hydration of sodium bicarbonate\n\n          -  Patients in dialysis\n\n          -  Emergency procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029820", 
            "org_study_id": "11/05339"
        }, 
        "intervention": {
            "arm_group_label": "RenalGuard", 
            "description": "Intravenous saline hydration matched with urine output, using the device Renalguard", 
            "intervention_name": "RenalGuard", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Contrast Nephropathy", 
            "Prevention", 
            "Renalguard"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "pesquisa@cardiarte.com.br", 
                "last_name": "Aryadina Piva, RN", 
                "phone": "55 51 3320 3494"
            }, 
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "RS", 
                    "zip": "90610-000"
                }, 
                "name": "Hospital S\u00e3o Lucas -PUCRS, Servi\u00e7o de Hemodin\u00e2mica"
            }, 
            "investigator": {
                "last_name": "Vitor O Gomes, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial", 
        "overall_contact": {
            "email": "pesquisa@cardiarte.com.br", 
            "last_name": "Aryadina Piva, RN", 
            "phone": "55 51 33203494"
        }, 
        "overall_official": {
            "affiliation": "Hospital Sao Lucas", 
            "last_name": "Vitor O Gomes, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Contrast-induced nephropathy defined as an increase of serum creatinine of 0.5mg/dl or 25% in pre procedure serum creatinine at 72h after procedure", 
            "measure": "Incidence of contrast-induced nephropathy", 
            "safety_issue": "No", 
            "time_frame": "72 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029820"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Sao Lucas da PUCRS", 
            "investigator_full_name": "Vitor Osorio Gomes", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hospital Sao Lucas da PUCRS", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Sao Lucas da PUCRS", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}